These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7608489)

  • 1. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.
    Marcellin P; Pouteau M; Benhamou JP
    J Hepatol; 1995 Mar; 22(3):364-9. PubMed ID: 7608489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C virus infection and thyroid diseases].
    Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
    Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
    Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
    J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing chronic hepatitis C virus infection.
    Lau JY; Davis GL
    BMJ; 1993 Feb; 306(6876):469-70. PubMed ID: 7680588
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon-alpha induced transient thyroid dysfunction in hepatitis C.
    Fernández-Díez S; Rodríguez-Agulló JL; Cascudo Rielo MJ; Navarro Angulo N; Díaz-Rubio M
    Rev Esp Enferm Dig; 2002 Mar; 94(3):159-63. PubMed ID: 12185880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy.
    Tran A; Quaranta JF; Benzaken S; Thiers V; Chau HT; Hastier P; Regnier D; Dreyfus G; Pradier C; Sadoul JL
    Hepatology; 1993 Aug; 18(2):253-7. PubMed ID: 7687977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
    Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
    J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thyroid function and autoimmunity in 215 patients seropositive for the hepatitis C virus].
    Nduwayo L; Bacq Y; Valat C; Goudeau A; Lecomte P
    Ann Endocrinol (Paris); 1998 Apr; 59(1):9-13. PubMed ID: 9752392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus antibody in patients with chronic autoimmune hepatitis: pitfalls in diagnosis and implications for treatment.
    Davis GL
    Mayo Clin Proc; 1991 Jun; 66(6):647-50. PubMed ID: 1646354
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
    Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
    Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia.
    Loviselli A; Oppo A; Velluzzi F; Atzeni F; Mastinu GL; Farci P; Orgiana G; Balestrieri A; Cocco PL; Mariotti S
    J Endocrinol Invest; 1999 Oct; 22(9):660-5. PubMed ID: 10595828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune thrombocytopenia and alpha-interferon therapy.
    Dourakis SP; Deutsch M; Hadziyannis SJ
    J Hepatol; 1996 Dec; 25(6):972-5. PubMed ID: 9007728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
    Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
    Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C virus, interferon alpha, and dysthyroidism].
    Marcellin P; Pouteau M; Messian O; Bok B; Erlinger S; Benhamou JP
    Gastroenterol Clin Biol; 1993; 17(12):887-91. PubMed ID: 8125219
    [No Abstract]   [Full Text] [Related]  

  • 18. Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma.
    Kiyosawa K; Tanaka E; Sodeyama T; Furuta K; Usuda S; Yousuf M; Furuta S
    Jpn J Cancer Res; 1990 Nov; 81(11):1089-91. PubMed ID: 2176199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IFN in the treatment of chronic viral hepatitis. Efficacy and tolerance of lymphoblastoid alpha interferon in HIV-negative drug addicts and associated chronic active hepatitis C].
    Acone N; B1ll'Aquila G; Magliocca M; Nigro FS; Pacifico P; Imparato L
    Clin Ter; 1994 Nov; 145(11):369-72. PubMed ID: 7534222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
    Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
    J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.